Eton Pharmaceuticals (ETON) Short Interest Ratio & Short Volume $14.49 +0.10 (+0.72%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$14.50 +0.01 (+0.05%) As of 02/21/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Eton Pharmaceuticals Short Interest DataEton Pharmaceuticals (ETON) has a short interest of 340,900 shares. This marks a 4.03% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.2, indicating that it would take 1.2 days of the average trading volume of 338,752 shares to cover all short positions.Current Short Interest340,900 sharesPrevious Short Interest327,700 sharesChange Vs. Previous Month+4.03%Dollar Volume Sold Short$6.03 millionShort Interest Ratio1.2 Days to CoverLast Record DateJanuary 31, 2025Outstanding Shares26,050,000 sharesPercentage of Shares Shorted1.31%Today's Trading Volume238,056 sharesAverage Trading Volume338,752 sharesToday's Volume Vs. Average70% Short Selling Eton Pharmaceuticals? Sign up to receive the latest short interest report for Eton Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartETON Short Interest Over TimeETON Days to Cover Over TimeETON Percentage of Float Shorted Over Time Eton Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/31/2025340,900 shares $6.03 million +4.0%N/A1.2 $17.68 1/15/2025327,700 shares $4.69 million +33.7%N/A1.3 $14.30 12/31/2024245,100 shares $3.26 million -11.8%N/A1.1 $13.32 12/15/2024278,000 shares $3.43 million +1.5%N/A1.3 $12.35 11/30/2024273,900 shares $3.71 million +32.6%1.1%1.2 $13.53 11/15/2024206,500 shares $2.07 million +7.6%0.8%1 $10.02 10/31/2024191,900 shares $1.63 million -6.2%0.8%1.2 $8.47 10/15/2024204,600 shares $1.72 million +62.0%0.8%1.5 $8.42 9/30/2024126,300 shares $757,800.00 +67.3%0.5%1 $6.00 9/15/202475,500 shares $388,825.00 +5.6%0.3%0.9 $5.15 Get the Latest News and Ratings for ETON and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Eton Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/31/202471,500 shares $328,900.00 +2.7%0.3%1.1 $4.60 8/15/202469,600 shares $279,096.00 -7.5%0.3%1.2 $4.01 7/31/202475,200 shares $270,720.00 +23.3%0.3%1.4 $3.60 7/15/202461,000 shares $203,740.00 -14.5%0.3%1.2 $3.34 6/30/202471,300 shares $234,577.00 -9.4%0.3%1.6 $3.29 6/15/202478,700 shares $280,172.00 +44.1%0.3%1.5 $3.56 5/31/202454,600 shares $193,830.00 -35.9%0.2%0.9 $3.55 5/15/202485,200 shares $310,980.00 -2.5%0.4%1.3 $3.65 4/30/202487,400 shares $305,900.00 -41.0%0.4%1.5 $3.50 4/15/2024148,100 shares $476,882.00 -32.8%0.7%2.4 $3.22 3/31/2024220,400 shares $826,500.00 -9.3%1.0%3.1 $3.75 3/15/2024242,900 shares $935,165.00 +6.9%1.1%3.2 $3.85 2/29/2024227,200 shares $1.01 million -38.0%1.0%3.2 $4.45 2/15/2024366,200 shares $1.68 million -4.6%1.6%5.3 $4.59 1/31/2024384,000 shares $1.79 million +0.7%1.7%4.6 $4.67 1/15/2024381,200 shares $1.67 million -14.5%1.7%4.5 $4.37 12/31/2023445,800 shares $1.95 million +22.5%2.0%5.1 $4.38 12/15/2023363,800 shares $1.62 million -41.4%1.6%3.8 $4.45 11/30/2023620,900 shares $2.20 million -17.6%2.8%4.9 $3.54 11/15/2023753,600 shares $2.78 million -21.1%3.4%4.7 $3.69 10/31/2023954,600 shares $4.03 million -5.5%4.3%2.1 $4.22 10/15/20231,010,000 shares $3.96 million +3.0%4.5%2.2 $3.92 9/30/2023980,700 shares $4.09 million +3.6%4.4%2.1 $4.17 9/15/2023946,700 shares $4.69 million -1.2%4.2%2.1 $4.95 8/31/2023958,600 shares $4.31 million -27.4%4.3%2.3 $4.50 8/15/20231,320,000 shares $6.26 million +150.1%5.9%3.5 $4.74 7/31/2023527,700 shares $1.49 million -6.2%2.4%9.6 $2.82 7/15/2023562,700 shares $1.67 million +3.8%2.5%11.5 $2.97 6/30/2023542,100 shares $1.89 million -1.8%2.4%11.8 $3.49 6/15/2023552,000 shares $2.02 million -1.9%2.5%12 $3.66Alert: DOGE goes live (Ad)"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what he might do next. And one widely followed Boston based think tank is stepping forward with their official playbook.Click here to learn more. 5/31/2023562,700 shares $2.23 million +6.1%2.5%11.4 $3.96 5/15/2023530,400 shares $1.88 million -9.7%2.4%11.1 $3.54 4/30/2023587,500 shares $2.13 million +7.4%2.7%12.1 $3.63 4/15/2023547,200 shares $1.93 million +6.9%2.5%9.4 $3.52 3/31/2023511,700 shares $1.97 million -1.3%2.3%7.7 $3.85 3/15/2023518,300 shares $1.97 million +11.0%2.4%7.7 $3.80 2/28/2023467,100 shares $1.74 million +5.5%2.1%7.2 $3.73 2/15/2023442,600 shares $1.54 million -5.8%2.0%6.6 $3.49 1/31/2023469,900 shares $1.64 million -14.1%2.1%6.3 $3.48 1/15/2023547,100 shares $1.91 million -10.9%2.5%7 $3.50 12/30/2022614,100 shares $1.73 million +16.0%2.8%8.9 $2.82 12/15/2022529,200 shares $1.72 million -6.4%2.4%7.4 $3.25 11/30/2022565,500 shares $1.71 million -13.7%2.6%8.8 $3.02 11/15/2022655,000 shares $2.01 million -1.4%3.0%10.1 $3.07 10/31/2022664,000 shares $1.69 million +1.2%3.0%9 $2.55 10/15/2022655,900 shares $1.43 million -6.5%3.0%9.9 $2.18 9/30/2022701,400 shares $1.47 million -1.6%3.2%3.9 $2.10 9/15/2022712,500 shares $1.56 million -1.7%3.2%3.7 $2.19 8/31/2022724,500 shares $1.64 million -12.2%3.3%3.8 $2.26 8/15/2022824,700 shares $2.21 million -9.9%4.0%4.1 $2.68 7/31/2022915,500 shares $2.45 million +32.0%4.4%4.9 $2.68 7/15/2022693,500 shares $1.93 million -3.1%3.3%3.8 $2.79 6/30/2022715,700 shares $1.88 million -2.4%3.4%5.9 $2.62 6/15/2022733,500 shares $2.16 million -4.5%3.5%6.3 $2.94 5/31/2022768,300 shares $2.34 million -9.9%3.7%6.6 $3.04 5/15/2022852,400 shares $2.65 million -2.2%4.1%7.5 $3.11 4/30/2022871,900 shares $3.08 million +0.5%4.3%7.4 $3.53 4/15/2022867,400 shares $3.36 million +33.1%4.3%5.9 $3.87 3/31/2022651,900 shares $2.84 million -7.2%N/A4.1 $4.36 3/15/2022702,300 shares $2.76 million +1.1%3.5%4.7 $3.93 2/28/2022694,700 shares $2.61 million -12.2%3.4%4.1 $3.76 2/15/2022791,100 shares $3.05 million -12.1%3.9%4 $3.85 1/31/2022900,100 shares $3.33 million +34.5%4.4%3.1 $3.70 1/15/2022669,100 shares $2.70 million +3.2%N/A1.8 $4.03 12/31/2021648,100 shares $2.78 million +5.7%3.2%1.7 $4.29 12/15/2021613,400 shares $2.44 million -7.2%3.0%1.7 $3.98 11/30/2021660,900 shares $2.58 million -8.2%3.3%1.9 $3.90 11/15/2021720,000 shares $3.68 million +36.0%3.6%2.1 $5.11 10/29/2021529,400 shares $3.05 million +8.6%2.6%1.4 $5.76 10/15/2021487,600 shares $2.54 million -32.3%2.4%1.3 $5.21 9/30/2021720,000 shares $3.63 million -41.0%3.6%2 $5.04 9/15/20211,220,000 shares $6.08 million -12.9%6.0%2.8 $4.98 8/31/20211,400,000 shares $7.38 million -17.2%6.9%2.1 $5.27 8/13/20211,690,000 shares $7.47 million +38.5%8.3%2.1 $4.42 7/30/20211,220,000 shares $6.27 million -6.2%6.0%1.6 $5.14 7/15/20211,300,000 shares $7.12 million -6.5%6.4%2.1 $5.48 6/30/20211,390,000 shares $8.56 million -22.8%6.9%2.2 $6.16 6/15/20211,800,000 shares $12.29 million +21.6%8.9%3.2 $6.83 5/28/20211,480,000 shares $10.45 million -3.9%7.3%3.9 $7.06 5/14/20211,540,000 shares $11.90 million +8.5%N/A6.8 $7.73Alert: DOGE goes live (Ad)"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what he might do next. And one widely followed Boston based think tank is stepping forward with their official playbook.Click here to learn more. 4/30/20211,420,000 shares $12.35 million +17.4%N/A7.3 $8.70 4/15/20211,210,000 shares $9.16 million +1.7%N/A0 $7.57 3/31/20211,190,000 shares $8.31 million +17.8%N/A7 $6.98 3/15/20211,010,000 shares $8.29 million +28.0%N/A5.8 $8.21 2/26/2021788,900 shares $6.50 million -2.3%4.5%4.5 $8.24 2/12/2021807,500 shares $7.90 million -13.7%4.6%4.7 $9.78 1/29/2021935,300 shares $8.50 million -3.4%5.4%5 $9.09 1/15/2021968,100 shares $8.83 million +7.1%5.6%4.7 $9.12 12/31/2020904,300 shares $7.33 million +6.2%5.2%3.5 $8.11 12/15/2020851,600 shares $7.47 million -18.1%4.9%2.4 $8.77 11/30/20201,040,000 shares $8.27 million No Change6.0%2.3 $7.95 11/15/20201,040,000 shares $7.50 million +3.0%6.0%2.1 $7.21 10/30/20201,010,000 shares $7.74 million -5.6%5.8%1.9 $7.66 10/15/20201,070,000 shares $8.31 million +18.0%6.6%1.8 $7.77 9/30/2020906,700 shares $7.16 million +14.4%6.4%1.7 $7.90 9/15/2020792,700 shares $6.25 million +18.4%5.6%1.7 $7.88 8/31/2020669,800 shares $5.25 million -9.4%4.7%1.8 $7.84 8/14/2020739,000 shares $5.23 million +1.6%5.2%2.5 $7.08 7/31/2020727,300 shares $4.86 million -3.1%5.2%2.9 $6.68 7/15/2020750,200 shares $3.77 million +33.1%5.3%5.8 $5.03 6/30/2020563,500 shares $3.18 million +100.7%4.0%4.7 $5.65 6/15/2020280,800 shares $1.45 million -3.3%2.0%3.6 $5.17 5/29/2020290,400 shares $1.33 million -36.8%2.1%3.5 $4.57 5/15/2020459,200 shares $2.18 million -0.5%3.3%5.8 $4.75 4/30/2020461,400 shares $2.31 million -1.8%3.4%5.5 $5.00 4/15/2020469,900 shares $1.95 million -2.1%3.7%5.7 $4.15 3/31/2020479,900 shares $2.26 million +44.5%3.9%5.8 $4.71 3/13/2020332,200 shares $1.45 million +24.7%3.0%4.3 $4.37 2/28/2020266,500 shares $796,835.00 +3.3%2.4%3.8 $2.99 ETON Short Interest - Frequently Asked Questions What is Eton Pharmaceuticals' current short interest? Short interest is the volume of Eton Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of January 31st, investors have sold 340,900 shares of ETON short. Learn More on Eton Pharmaceuticals' current short interest. What is a good short interest ratio for Eton Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ETON shares currently have a short interest ratio of 1.0. Learn More on Eton Pharmaceuticals's short interest ratio. Which institutional investors are shorting Eton Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Eton Pharmaceuticals: Group One Trading LLC, Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Eton Pharmaceuticals' short interest increasing or decreasing? Eton Pharmaceuticals saw a increase in short interest in January. As of January 31st, there was short interest totaling 340,900 shares, an increase of 4.0% from the previous total of 327,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Eton Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Eton Pharmaceuticals: NewAmsterdam Pharma (4.62%), Apogee Therapeutics, Inc. (24.33%), Belite Bio, Inc (0.20%), Travere Therapeutics, Inc. (12.25%), Disc Medicine, Inc. (12.11%), Wave Life Sciences Ltd. (6.16%), Iovance Biotherapeutics, Inc. (26.04%), Evotec SE (0.22%), Praxis Precision Medicines, Inc. (15.21%), Amphastar Pharmaceuticals, Inc. (11.54%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.21 billion), Charter Communications, Inc. ($4.07 billion), Reddit, Inc. ($3.33 billion), The Kroger Co. ($2.67 billion), Cencora, Inc. ($2.29 billion), Hims & Hers Health, Inc. ($2.17 billion), SoFi Technologies, Inc. ($1.99 billion), Live Nation Entertainment, Inc. ($1.87 billion), Rivian Automotive, Inc. ($1.76 billion), and Moderna, Inc. ($1.60 billion). View all of the most shorted stocks. What does it mean to sell short Eton Pharmaceuticals stock? Short selling ETON is an investing strategy that aims to generate trading profit from Eton Pharmaceuticals as its price is falling. ETON shares are trading up $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Eton Pharmaceuticals? A short squeeze for Eton Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ETON, which in turn drives the price of the stock up even further. How often is Eton Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ETON, twice per month. The most recent reporting period available is January, 31 2025. More Short Interest Resources from MarketBeat Related Companies NewAmsterdam Pharma Short Interest Apogee Therapeutics Short Interest Belite Bio Short Interest Travere Therapeutics Short Interest Disc Medicine Short Interest Wave Life Sciences Short Interest Iovance Biotherapeutics Short Interest Evotec Short Interest Praxis Precision Medicines Short Interest Amphastar Pharmaceuticals Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ETON) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredHow to trade Executive Order 14154Trump’s pen must be running out of ink… Since he returned to office he’s signed more than 50 Executive Orde...Porter & Company | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eton Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Eton Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ETON Stock Alerts